The Optimum Strategic Communications European VC Report confirmed that there is a … Continue reading “Recommendations following our EU Healthcare Investor Survey 2020”
co-hosted with Dechert LLP, Thursday 8th October 2020. The first speakers to be announced…
A video panel by Optimum in partnership with One Nucleus for ON Helix event held virtually in July 2020
Phase 2 data from Arix portfolio company Amplyx and why anti-infectives are especially important now during the pandemic.
Who are the women blazing trails in biopharma R&D and leading the fight against Covid-19?
Optimum is proud to sponsor the 2020 European Mediscience Award for Best … Continue reading “Optimum sponsors of the European Mediscience Award for Best Communications”
Read more on VelosBio in this latest blog post by Arix Managing Director and VelosBio Board Director Jonathan Tobin
As many countries continue to pass the peak of COVID-19, Masters Speciality … Continue reading “Pharmaceuticals vs Covid-19 | Half-Time Report by Sid Masters, Masters Pharma”
Since taking over as CEO of Calliditas Therapeutics in 2017, Renee Aguiar-Lucander … Continue reading “Optimum Video Q&A: Getting to know Renee Aguiar-Lucander”
Are you sitting comfortably? Do you notice your breathing, all nice and easy? Now, try taking a straw and breathing just through that. Not quite so easy is it?
This is a fantastic initiative that helps young businesses by providing the support they need to succeed. This includes up to USD 500,000 in fundraising, introduction to a dynamic network and access to free lab space.
Has Kiadis Found Immunotherapy’s Killer App? In Amsterdam, there has just been a glimpse of the future of cellular medicine.
Watch the full interview here Mike Ward, Global Head of Thought Leadership, … Continue reading “Optimum Q&A: Getting to know Dr. Cedric Francois, CEO of Apellis Pharmaceuticals”
Today, on International Nurses Day, at a time when clinical trials are being discussed on a daily basis regarding the COVID-19 crisis, Cure Leukaemia highlights how the crisis could impact blood cancer patients
Check out In Vivo’s list of “ones to watch” in Biopharma and Medtech. Optimum clients Derk Arts, Castor CEO, Jason Foster, Ori Biotech CEO and Greg Mullen, Theragnostics CEO recognised for “bringing something new to the game”.
RNA epigenetics is an “untapped druggable space” that could be the next … Continue reading “RNA epigenetics – an emerging, innovative area of drug discovery”
Optimum aims to provide you with the most informative insights on the … Continue reading “COVID 19: Free news & resources”
“A viable therapeutic would dramatically change the tone of the COVID-19 pandemic, giving hope and a path to eradicating the virus, saving lives and livelihoods.”
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...GET IN TOUCH